104 related articles for article (PubMed ID: 38782427)
1. Diagnostic and therapeutic challenges in a recurrent endometrial carcinoma in lung, 15 years after primary treatment.
Upadhyay AK; Kumar M; Prakash A; Kumar A
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38782427
[TBL] [Abstract][Full Text] [Related]
2. Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer.
van Weelden WJ; Lalisang RI; Bulten J; Lindemann K; van Beekhuizen HJ; Trum H; Boll D; Werner HMJ; van Lonkhuijzen LRCW; Yigit R; Forsse D; Witteveen PO; Galaal K; van Ginkel A; Bignotti E; Weinberger V; Sweegers S; Kroep JR; Cabrera S; Snijders MPLM; Inda MA; Eriksson AGZ; ; Krakstad C; Romano A; van de Stolpe A; Pijnenborg JMA
Am J Obstet Gynecol; 2021 Oct; 225(4):407.e1-407.e16. PubMed ID: 34019887
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
Thigpen T; Brady MF; Homesley HD; Soper JT; Bell J
J Clin Oncol; 2001 Jan; 19(2):364-7. PubMed ID: 11208827
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy plus sequential hormonal therapy for advanced and recurrent endometrial carcinoma: a phase II study.
Pinelli DM; Fiorica JV; Roberts WS; Hoffman MS; Nicosia SV; Cavanagh D
Gynecol Oncol; 1996 Mar; 60(3):462-7. PubMed ID: 8774658
[TBL] [Abstract][Full Text] [Related]
5. [The first Mexican consensus of endometrial cancer. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México].
Ruvalcaba-Limón E; Cantú-de-León D; León-Rodríguez E; Cortés-Esteban P; Serrano-Olvera A; Morales-Vásquez F; Sosa-Sánchez R; Poveda-Velasco A; Crismatt-Zapata A; Santillán-Gómez A; Aguilar-Jiménez C; Alanís-López P; Alfaro-Ramírez P; Alvarez-Avitia MA; Aranda-Flores CE; Arias-Ceballos JH; Arrieta-Rodríguez O; Barragán-Curiel E; Botello-Hernández D; Brom-Valladares R; Cabrera-Galeana PA; Cantón-Romero JC; Capdeville-García D; Cárdenas-Sánchez J; Castorena-Roji G; Cepeda-López FR; Cervantes-Sánchez G; Cetina-Pérez Lde C; Coronel-Martínez JA; Cortés-Cárdenas SA; Cruz-López JC; de la Garza-Salazar JG; Díaz-Romero C; Dueñas-González A; Valle-Solís AE; Escudero-de los Ríos P; Flores-Alvarez E; García-Matus R; Gerson-Cwilich R; González-Enciso A; González-de-León C; Guevara-Torres AG; Herbert-Núñez GS; Hernández-Hernández C; Hernández-Hernández DM; Isla-Ortiz D; Jesús-Sandoval R; Jiménez-Cervantes C; Kuri-Exsome R; López-Obispo JL; Maffuz-Aziz A; Martínez-Barrera LM; Medina-Castro JM; Montalvo-Esquivel G; Mora-Aguilar VH; Morales-Palomares MA; Morán-Mendoza A; Morgan-Villela G; Mota-García A; Muñoz-González DE; Murillo-Cruz DA; Novoa-Vargas A; Ochoa-Carrillo FJ; Oñate-Ocaña LF; Ortega-Rojo A; Palacios-Martínez AG; Palomeque-López A; Pérez-Montiel MD; Quijano-Castro F; Rivera-Rivera S; Rivera-Rubí LM; Robles-Flores JU; Rodríguez-Trejo A; Salas-Gonzáles E; Silva JA; Solorza-Luna G; Souto-del-Bosque R; Tirado-Gómez LL; Torrescano-González S; Torres-Lobatón A; Trejo-Durán E; Villavicencio-Valencia V; Gallardo-Rincón D;
Rev Invest Clin; 2010; 62(6):583, 585-605. PubMed ID: 21416918
[TBL] [Abstract][Full Text] [Related]
6. Non-exenterative surgical management of recurrent endometrial carcinoma.
Moukarzel LA; Braxton KF; Zhou QC; Pedra Nobre S; Iasonos A; Alektiar KM; Tew WP; Abu-Rustum NR; Leitao MM; Chi DS; Mueller JJ
Gynecol Oncol; 2021 Aug; 162(2):268-276. PubMed ID: 34090704
[TBL] [Abstract][Full Text] [Related]
7. Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882).
Pandya KJ; Yeap BY; Weiner LM; Krook JE; Erban JK; Schinella RA; Davis TE
Am J Clin Oncol; 2001 Feb; 24(1):43-6. PubMed ID: 11232948
[TBL] [Abstract][Full Text] [Related]
8. Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.
Fleming GF; Filiaci VL; Marzullo B; Zaino RJ; Davidson SA; Pearl M; Makker V; Burke JJ; Zweizig SL; Van Le L; Hanjani P; Downey G; Walker JL; Reyes HD; Leslie KK
Gynecol Oncol; 2014 Mar; 132(3):585-92. PubMed ID: 24456823
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival in low-grade endometrial stromal sarcoma with childbirth and multidisciplinary treatment: a case report.
Maeda O; Moritani S; Ichihara S; Inoue T; Ishihara Y; Yamamoto S; Ito M; Matsumura Y; Sugiyama K; Horio M; Kondo I
J Med Case Rep; 2015 Oct; 9():233. PubMed ID: 26481040
[TBL] [Abstract][Full Text] [Related]
10. SEOM guidelines for endometrial cancer.
Oaknin A; Rodríguez-Freixinós V; Díaz de Corcuera I; Rivera F; del Campo JM;
Clin Transl Oncol; 2012 Jul; 14(7):512-5. PubMed ID: 22721795
[TBL] [Abstract][Full Text] [Related]
11. Synchronous Well-differentiated Endometrioid Adenocarcinoma and Leiomyosarcoma of the Uterus With Pulmonary Metastasis in a 50-Yr-Old Woman: A Case Report and Review of Literature.
Abbas A; Ud Din N; Kayani N
Int J Gynecol Pathol; 2020 Jul; 39(4):373-378. PubMed ID: 31157684
[TBL] [Abstract][Full Text] [Related]
12. [Treatment and prognosis of low-grade malignant endometrial stromal sarcoma].
Ma SK; Zhang HT; Wu LY; Liu LY; Li B
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):74-8. PubMed ID: 17575701
[TBL] [Abstract][Full Text] [Related]
13. Advanced and recurrent endometrial carcinoma: hormonal therapy.
Lentz SS
Semin Oncol; 1994 Feb; 21(1):100-6. PubMed ID: 8310300
[No Abstract] [Full Text] [Related]
14. Hormone therapy for patients with advanced or recurrent endometrial cancer.
Lee WL; Yen MS; Chao KC; Yuan CC; Ng HT; Chao HT; Lee FK; Wang PH
J Chin Med Assoc; 2014 May; 77(5):221-6. PubMed ID: 24694672
[TBL] [Abstract][Full Text] [Related]
15. Successful salvage treatment of recurrent endometrial cancer with multiple lung and abdominal metastases.
Hsu LH; Chen YP; Chang HP; Chen YR; Hong JH; Chao A; Lai CH
Eur J Gynaecol Oncol; 2011; 32(2):218-20. PubMed ID: 21614922
[TBL] [Abstract][Full Text] [Related]
16. Upfront radiotherapy with brachytherapy for medically inoperable and unresectable patients with high-risk endometrial cancer.
Gannavarapu BS; Hrycushko B; Jia X; Albuquerque K
Brachytherapy; 2020; 19(2):139-145. PubMed ID: 32061534
[TBL] [Abstract][Full Text] [Related]
17. Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: a comparative study in 363 patients.
Ngô C; Brugier C; Plancher C; de la Rochefordière A; Alran S; Féron JG; Malhaire C; Scholl S; Sastre X; Rouzier R; Fourchotte V;
Eur J Surg Oncol; 2014 Oct; 40(10):1237-44. PubMed ID: 25086993
[TBL] [Abstract][Full Text] [Related]
18. The clinical management of inoperable endometrial carcinoma.
Palisoul M; Mutch DG
Expert Rev Anticancer Ther; 2016 May; 16(5):515-21. PubMed ID: 26999568
[TBL] [Abstract][Full Text] [Related]
19. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
[TBL] [Abstract][Full Text] [Related]
20. L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results.
Bosse T; Nout RA; Stelloo E; Dreef E; Nijman HW; Jürgenliemk-Schulz IM; Jobsen JJ; Creutzberg CL; Smit VT
Eur J Cancer; 2014 Oct; 50(15):2602-10. PubMed ID: 25126672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
